Jacobi Capital Management
CTSO icon

Jacobi Capital Management’s Cytosorbents Corp CTSO Stock Holding History

Jacobi Capital Management’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-5
Closed -$1K – 1369
2020
Q4 		$1K Buy
+5
New +$837 ﹤0.01% 1215
2016
Q4 		– Sell
-250
Closed -$33K – 626
2016
Q3 		$33K Hold
250
– – 0.02% 303
2016
Q2 		$23K Buy
+250
New +$21.8K 0.01% 325

Other funds holding CTSO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Redmile Group
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Skylands Capital
Skylands Capital Milwaukee, Wisconsin $762M AUM 14.92% 1-Year Est. Return
Granahan Investment Management
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Sargent Investment Group
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jacobi Capital Management's CTSO Position: Q1 2021 in Review

Jacobi Capital Management sold out of Cytosorbents Corp (CTSO) in Q1 2021, closing a stake of 5 shares — an estimated $1K sold.

Jacobi Capital Management first reported a position in CTSO in Q2 2016 and held it in 3 quarters. The position peaked at $33K in Q3 2016. 95 funds tracked by Wall St. Rank hold CTSO as of Q1 2021.

  • Jacobi Capital Management reported no remaining Cytosorbents Corp position as of Q1 2021 after selling out during the quarter.
  • Jacobi Capital Management sold 5 Cytosorbents Corp shares in Q1 2021, an estimated $1K.
  • Jacobi Capital Management first reported a position in Cytosorbents Corp in Q2 2016 and held it in 3 quarters.
  • Jacobi Capital Management's Cytosorbents Corp position peaked at $33K in Q3 2016.
  • 95 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2021.

Based on Jacobi Capital Management's 13F filing for Q1 2021, filed 11 May 2021.